Home  >  News
Eppen_CellXpert_Feb25
Waters_Ebook_Dec24
you can get e-magazine links on WhatsApp. Click here
Marketing + Font Resize -

Lupin introduces Minzoya in US market

Our Bureau, Mumbai
Monday, January 13, 2025, 16:40 Hrs  [IST]

Global pharma major Lupin Limited (Lupin) announced the launch of the United States Food and Drug Administration (FDA) approved Minzoya (levonorgestrel and ethinyl estradiol tablets, USP and ferrous bisglycinate tablets), 0.1 mg/0.02 mg and 36.5 mg.
 
Minzoya (levonorgestrel and ethinyl estradiol tablets, USP and ferrous bisglycinate tablets) 0.1 mg/0.02 mg and 36.5 mg is a generic equivalent of Balcoltra (levonorgestrel and ethinyl estradiol tablets, USP and ferrous bisglycinate tablets) 0.1 mg/0.02 mg and 36.5 mg, of Avion Pharmaceuticals LLC., indicated for use by females of reproductive potential to prevent pregnancy.
 
Levonorgestrel and ethinyl estradiol tablets, USP and ferrous bisglycinate tablets (Balcoltra) had an estimated annual sale of USD 24 million in the US (IQVIA MAT November 2024).

 

*POST YOUR COMMENT
Comments
* Name :     
* Email :    
  Website :  
   
     
 
Avians_2025
Asia_Lab_Expo2025
chemexpoindia
ana-Lab-India_25
Copyright © 2024 Saffron Media Pvt. Ltd | twitter
 
linkedin
 
 
linkedin
 
instagram